bcr_patient_uuid	bcr_patient_barcode	bcr_drug_barcode	bcr_drug_uuid	form_completion_date	pharmaceutical_therapy_drug_name	clinical_trial_drug_classification	pharmaceutical_therapy_type	pharmaceutical_tx_started_days_to	pharmaceutical_tx_ongoing_indicator	pharmaceutical_tx_ended_days_to	treatment_best_response	pharma_adjuvant_cycles_count	pharma_type_other	pharmaceutical_tx_dose_units	pharmaceutical_tx_total_dose_units	prescribed_dose	regimen_number	route_of_administration	therapy_regimen	therapy_regimen_other	total_dose	tx_on_clinical_trial
bcr_patient_uuid	bcr_patient_barcode	bcr_drug_barcode	bcr_drug_uuid	form_completion_date	drug_name	clinical_trail_drug_classification	therapy_type	days_to_drug_therapy_start	therapy_ongoing	days_to_drug_therapy_end	measure_of_response	number_cycles	therapy_type_notes	prescribed_dose_units	total_dose_units	prescribed_dose	regimen_number	route_of_administration	regimen_indication	regimen_indication_notes	total_dose	tx_on_clinical_trial
CDE_ID:	CDE_ID:2673794	CDE_ID:	CDE_ID:	CDE_ID:	CDE_ID:2975232	CDE_ID:3378323	CDE_ID:2793530	CDE_ID:3392465	CDE_ID:3103479	CDE_ID:3392470	CDE_ID:2857291	CDE_ID:62590	CDE_ID:2001762	CDE_ID:3065815	CDE_ID:3088785	CDE_ID:2184728	CDE_ID:2673845	CDE_ID:2003586	CDE_ID:2793511	CDE_ID:2793516	CDE_ID:1515	CDE_ID:3925111
ab9cc98a-86ae-4913-bcb2-cc3aeff8abb1	TCGA-G4-6298	TCGA-G4-6298-D21968	b201fb4c-7422-447a-87c1-c46516ed2b91	2012-1-20	Irinotecan	[Not Available]	Chemotherapy	412	NO	462	[Not Available]	4	[Not Available]	mg	mg	176	1	IV	PROGRESSION	[Not Applicable]	704	[Not Available]
ab9cc98a-86ae-4913-bcb2-cc3aeff8abb1	TCGA-G4-6298	TCGA-G4-6298-D21967	4b271363-fb42-41fc-ba0a-4a1866ebd1d7	2012-1-20	Erbitux	[Not Available]	Chemotherapy	412	NO	462	[Not Available]	4	[Not Available]	mg	mg	440	1	IV	PROGRESSION	[Not Applicable]	1760	[Not Available]
23252dca-e836-47a0-b294-758ad60aa259	TCGA-G4-6299	TCGA-G4-6299-D22029	f7f479e8-c97f-4318-841c-4093a7451dfc	2012-1-20	Bevacizumab	[Not Available]	Other, specify in notes	38	NO	363	[Not Available]	24	Phase III Clinical Trial	mg/kg	mg/kg	5	1	IV	ADJUVANT	[Not Applicable]	120	[Not Available]
23252dca-e836-47a0-b294-758ad60aa259	TCGA-G4-6299	TCGA-G4-6299-D22030	7c7ee768-9568-4ec4-9026-3ce737ed05dc	2012-1-20	Leucovorin	[Not Available]	Other, specify in notes	38	NO	192	[Not Available]	12	Phase III Clinical Trial	[Not Available]	[Not Available]	[Not Available]	1	IV	ADJUVANT	[Not Applicable]	[Not Available]	[Not Available]
23252dca-e836-47a0-b294-758ad60aa259	TCGA-G4-6299	TCGA-G4-6299-D22032	cdfa4fa2-4682-4fc8-883a-185c52a8986d	2012-1-20	Oxaliplatin	[Not Available]	Other, specify in notes	38	NO	192	[Not Available]	12	Phase III Clinical Trial	[Not Available]	[Not Available]	[Not Available]	1	IV	ADJUVANT	[Not Applicable]	[Not Available]	[Not Available]
23252dca-e836-47a0-b294-758ad60aa259	TCGA-G4-6299	TCGA-G4-6299-D22033	3a112e40-6f15-46f9-a153-7cf96e71c8f4	2012-1-20	Fluorouracil	[Not Available]	Other, specify in notes	38	NO	192	[Not Available]	12	Phase III Clinical Trial	[Not Available]	[Not Available]	[Not Available]	1	IV	ADJUVANT	[Not Applicable]	[Not Available]	[Not Available]
264c0d45-078a-4207-a101-71f99bcd237e	TCGA-G4-6303	TCGA-G4-6303-D21601	fbdd2907-7af7-4844-b7e9-b01ee80daa88	2012-1-23	Oxaliplatin	[Not Available]	Chemotherapy	516	NO	682	[Not Available]	6	[Not Available]	mg	mg	165	1	IV	PROGRESSION	[Not Applicable]	990	[Not Available]
264c0d45-078a-4207-a101-71f99bcd237e	TCGA-G4-6303	TCGA-G4-6303-D21725	b33e676e-a8c1-4fa6-9015-db6d44507b9d	2012-1-23	Erbitux	[Not Available]	Chemotherapy	1596	NO	1838	[Not Available]	12	[Not Available]	[Not Available]	[Not Available]	[Not Available]	4	[Not Available]	PROGRESSION	[Not Applicable]	[Not Available]	[Not Available]
264c0d45-078a-4207-a101-71f99bcd237e	TCGA-G4-6303	TCGA-G4-6303-D21717	34bd5fb4-ebfa-4d5b-9ae9-96be74c05bf1	2012-1-23	Leucovorin	[Not Available]	Chemotherapy	1443	NO	1596	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	3	[Not Available]	PROGRESSION	[Not Applicable]	[Not Available]	[Not Available]
264c0d45-078a-4207-a101-71f99bcd237e	TCGA-G4-6303	TCGA-G4-6303-D21602	d5338126-8849-4359-bd0e-9639362668d3	2012-1-23	5-FU	[Not Available]	Chemotherapy	516	NO	682	[Not Available]	6	[Not Available]	mg	mg	660	1	IV	PROGRESSION	[Not Applicable]	3960	[Not Available]
264c0d45-078a-4207-a101-71f99bcd237e	TCGA-G4-6303	TCGA-G4-6303-D21722	8513635f-8463-49de-83f2-6c54d479b728	2012-1-23	5-FU	[Not Available]	Chemotherapy	1443	NO	1596	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	3	[Not Available]	PROGRESSION	[Not Applicable]	[Not Available]	[Not Available]
264c0d45-078a-4207-a101-71f99bcd237e	TCGA-G4-6303	TCGA-G4-6303-D21790	8D7F0299-6CC1-4878-AD8D-EFDA900B42D1	2012-1-23	Bevacizumab	[Not Available]	Chemotherapy	1840	NO	1994	[Not Available]	10	[Not Available]	mg	mg	325	5	IV	PROGRESSION	[Not Applicable]	3240	[Not Available]
264c0d45-078a-4207-a101-71f99bcd237e	TCGA-G4-6303	TCGA-G4-6303-D21603	57970f69-f63f-427e-bf68-86d90b0f5ac8	2012-1-23	Avastin	[Not Available]	Chemotherapy	896	NO	1443	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	2	[Not Available]	PROGRESSION	[Not Applicable]	[Not Available]	[Not Available]
264c0d45-078a-4207-a101-71f99bcd237e	TCGA-G4-6303	TCGA-G4-6303-D21605	7a35095d-25fa-4780-95aa-88c2c4032d95	2012-1-23	5-FU	[Not Available]	Chemotherapy	896	NO	1443	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	2	[Not Available]	PROGRESSION	[Not Applicable]	[Not Available]	[Not Available]
264c0d45-078a-4207-a101-71f99bcd237e	TCGA-G4-6303	TCGA-G4-6303-D21604	469d1453-719a-4bec-bf80-abd497cca359	2012-1-23	Leucovorin	[Not Available]	Chemotherapy	896	NO	1443	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	2	[Not Available]	PROGRESSION	[Not Applicable]	[Not Available]	[Not Available]
264c0d45-078a-4207-a101-71f99bcd237e	TCGA-G4-6303	TCGA-G4-6303-D21720	fa5d0604-06c3-454e-9925-da7bf7285324	2012-1-23	Irinotecan	[Not Available]	Chemotherapy	1443	NO	1596	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	3	[Not Available]	PROGRESSION	[Not Applicable]	[Not Available]	[Not Available]
264c0d45-078a-4207-a101-71f99bcd237e	TCGA-G4-6303	TCGA-G4-6303-D21727	d26c7bb7-87f7-4960-9ed4-8ef58ac71e95	2012-1-23	Irinotecan	[Not Available]	Chemotherapy	1596	NO	1838	[Not Available]	12	[Not Available]	[Not Available]	[Not Available]	[Not Available]	4	[Not Available]	PROGRESSION	[Not Applicable]	[Not Available]	[Not Available]
264c0d45-078a-4207-a101-71f99bcd237e	TCGA-G4-6303	TCGA-G4-6303-D21600	30f4a7a0-2e8d-4001-b5ff-cc4797c7fd66	2012-1-23	Leucovorin	[Not Available]	Chemotherapy	516	NO	682	[Not Available]	6	[Not Available]	mg	mg	660	1	IV	PROGRESSION	[Not Applicable]	3960	[Not Available]
264c0d45-078a-4207-a101-71f99bcd237e	TCGA-G4-6303	TCGA-G4-6303-D21793	57D9E884-76A1-4676-9427-18237D676857	2012-1-23	Leucovorin	[Not Available]	Chemotherapy	1840	NO	1994	[Not Available]	10	[Not Available]	mg	mg	680	5	IV	PROGRESSION	[Not Applicable]	6790	[Not Available]
264c0d45-078a-4207-a101-71f99bcd237e	TCGA-G4-6303	TCGA-G4-6303-D21794	5CEB94A7-D009-4796-A6B3-E5D560CC9B81	2012-1-23	5-FU	[Not Available]	Chemotherapy	1840	NO	1994	[Not Available]	10	[Not Available]	[Not Available]	[Not Available]	[Not Available]	5	IV	PROGRESSION	[Not Applicable]	[Not Available]	[Not Available]
264c0d45-078a-4207-a101-71f99bcd237e	TCGA-G4-6303	TCGA-G4-6303-D21789	c92c9a04-8347-4909-960b-0f4878f27b08	2012-1-23	Oxaliplatin	[Not Available]	Chemotherapy	1840	NO	1994	[Not Available]	10	[Not Available]	mg	mg	145	5	IV	PROGRESSION	[Not Applicable]	1450	[Not Available]
567ddc8e-2b00-417d-a326-479cb02e08dd	TCGA-G4-6304	TCGA-G4-6304-D21879	acd0a481-2c9c-4f44-8241-5c356396a8e8	2012-2-6	Leucovorin	[Not Available]	Chemotherapy	46	NO	258	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	1	[Not Available]	ADJUVANT	[Not Applicable]	[Not Available]	[Not Available]
567ddc8e-2b00-417d-a326-479cb02e08dd	TCGA-G4-6304	TCGA-G4-6304-D21877	3ebc93a4-f712-4cce-bf92-ac8e144d6365	2012-2-6	Oxaliplatin	[Not Available]	Chemotherapy	46	NO	258	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	1	[Not Available]	ADJUVANT	[Not Applicable]	[Not Available]	[Not Available]
567ddc8e-2b00-417d-a326-479cb02e08dd	TCGA-G4-6304	TCGA-G4-6304-D21873	dd809433-8215-46dc-84c1-61087ef5c99b	2012-2-6	Fluorouracil	[Not Available]	Chemotherapy	46	NO	258	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	1	[Not Available]	ADJUVANT	[Not Applicable]	[Not Available]	[Not Available]
e4be17c8-0855-432c-bb80-28bb24b62f32	TCGA-G4-6309	TCGA-G4-6309-D21947	0104d92b-90fe-42c8-9f02-dd916ce7b46f	2012-2-6	Xeloda	[Not Available]	Chemotherapy	73	NO	254	[Not Available]	8	[Not Available]	mg/day	mg	3600	1	PO	ADJUVANT	[Not Applicable]	355600	[Not Available]
14c13b05-abfe-472e-83a9-b28f60e58ad8	TCGA-G4-6310	TCGA-G4-6310-D21935	5e979430-9982-4b1b-8485-4805ba371049	2012-1-25	Xeloda	[Not Available]	Chemotherapy	90	NO	132	[Not Available]	[Not Available]	[Not Available]	mg/day	mg	3000	2	PO	ADJUVANT	[Not Applicable]	90000	[Not Available]
14c13b05-abfe-472e-83a9-b28f60e58ad8	TCGA-G4-6310	TCGA-G4-6310-D21936	1b57d686-2c1f-43ea-a842-1360b246b826	2012-1-25	Oxaliplatin	[Not Available]	Chemotherapy	153	NO	194	[Not Available]	4	[Not Available]	mg	mg	170	3	IV	ADJUVANT	[Not Applicable]	680	[Not Available]
14c13b05-abfe-472e-83a9-b28f60e58ad8	TCGA-G4-6310	TCGA-G4-6310-D21937	7648d80e-9205-4675-b34d-f82fa7ab36a7	2012-1-25	Leucovorin	[Not Available]	Other, specify in notes	153	NO	194	[Not Available]	4	Ancillary	mg	mg	800	3	IV	ADJUVANT	[Not Applicable]	3200	[Not Available]
14c13b05-abfe-472e-83a9-b28f60e58ad8	TCGA-G4-6310	TCGA-G4-6310-D21938	477f4c3c-ef6e-4873-9d95-3b1aa1e0d9a9	2012-1-25	5-FU	[Not Available]	Chemotherapy	153	NO	194	[Not Available]	4	[Not Available]	[Not Available]	[Not Available]	[Not Available]	3	[Not Available]	ADJUVANT	[Not Applicable]	[Not Available]	[Not Available]
14c13b05-abfe-472e-83a9-b28f60e58ad8	TCGA-G4-6310	TCGA-G4-6310-D21928	cb1310c0-860e-4d70-a72e-96e0fdc38613	2012-1-25	Oxaliplatin	[Not Available]	Chemotherapy	34	NO	76	[Not Available]	4	[Not Available]	mg	mg	180	1	IV	ADJUVANT	[Not Applicable]	684	[Not Available]
14c13b05-abfe-472e-83a9-b28f60e58ad8	TCGA-G4-6310	TCGA-G4-6310-D21933	892163e8-62fc-4fbe-a0ed-712508e46f84	2012-1-25	Leucovorin	[Not Available]	Other, specify in notes	34	NO	76	[Not Available]	4	Ancillary	mg	mg	840	1	IV	ADJUVANT	[Not Applicable]	3200	[Not Available]
14c13b05-abfe-472e-83a9-b28f60e58ad8	TCGA-G4-6310	TCGA-G4-6310-D21934	ced5bc62-7f2c-48e6-b830-f6f4a131fb03	2012-1-25	5-FU	[Not Available]	Chemotherapy	34	NO	76	[Not Available]	4	[Not Available]	[Not Available]	[Not Available]	[Not Available]	1	[Not Available]	ADJUVANT	[Not Applicable]	[Not Available]	[Not Available]
79d33c28-a7e2-4fca-8be1-a16fb6d68d49	TCGA-G4-6311	TCGA-G4-6311-D21923	1e9c5fe9-4666-4187-ab0c-6c2b09dc240a	2012-1-27	Leucovorin	[Not Available]	Chemotherapy	36	NO	190	[Not Available]	12	[Not Available]	mg/m2	mg/m2	400	1	IV	ADJUVANT	[Not Applicable]	4800	[Not Available]
79d33c28-a7e2-4fca-8be1-a16fb6d68d49	TCGA-G4-6311	TCGA-G4-6311-D21921	47dfca4c-93b9-421c-be8f-617d251452ae	2012-1-27	Oxaliplatin	[Not Available]	Chemotherapy	36	NO	148	[Not Available]	9	[Not Available]	mg	mg	152	1	IV	ADJUVANT	[Not Applicable]	1369	[Not Available]
79d33c28-a7e2-4fca-8be1-a16fb6d68d49	TCGA-G4-6311	TCGA-G4-6311-D21922	f10cb485-4558-454a-9a1e-905a5cabba57	2012-1-27	Fluorouracil	[Not Available]	Chemotherapy	36	NO	190	[Not Available]	12	[Not Available]	mg/m2	mg/m2	400	1	IV	ADJUVANT	[Not Applicable]	4800	[Not Available]
abe658e0-33f9-4f57-849b-dec4d20964d6	TCGA-G4-6314	TCGA-G4-6314-D21817	cf59cdd0-7a94-4432-90cf-15a5b6c41bc2	2012-2-9	Leucovorin	[Not Available]	Chemotherapy	337	NO	561	[Not Available]	17	[Not Available]	mg	mg	740	3	IV	PROGRESSION	[Not Applicable]	12464	[Not Available]
abe658e0-33f9-4f57-849b-dec4d20964d6	TCGA-G4-6314	TCGA-G4-6314-D21819	25e50ae8-9511-4f12-b1c4-73a2e8b2b2cc	2012-2-9	Irinotecan	[Not Available]	Chemotherapy	337	NO	561	[Not Available]	17	[Not Available]	mg	mg	240	3	IV	PROGRESSION	[Not Applicable]	3874	[Not Available]
abe658e0-33f9-4f57-849b-dec4d20964d6	TCGA-G4-6314	TCGA-G4-6314-D21815	7e1069d3-9265-49bc-a9dd-2004971ed7bb	2012-2-9	Bevacizumab	[Not Available]	Chemotherapy	337	NO	561	[Not Available]	17	[Not Available]	mg	mg	386	3	IV	PROGRESSION	[Not Applicable]	6404	[Not Available]
abe658e0-33f9-4f57-849b-dec4d20964d6	TCGA-G4-6314	TCGA-G4-6314-D21810	17ca7309-e359-4399-9b2f-67b7fbe11468	2012-2-9	Leucovorin	[Not Available]	Chemotherapy	48	NO	209	[Not Available]	12	[Not Available]	mg	mg	756	1	IV	ADJUVANT	[Not Applicable]	8976	[Not Available]
abe658e0-33f9-4f57-849b-dec4d20964d6	TCGA-G4-6314	TCGA-G4-6314-D21813	d2536ed5-5f4a-4cda-a592-2ff4aac998f2	2012-2-9	Oxaliplatin	[Not Available]	Chemotherapy	48	NO	181	[Not Available]	10	[Not Available]	mg	mg	160	1	IV	ADJUVANT	[Not Applicable]	1577	[Not Available]
abe658e0-33f9-4f57-849b-dec4d20964d6	TCGA-G4-6314	TCGA-G4-6314-D21822	1b0ba903-4ca7-483f-bf97-9e3138b7afdc	2012-2-9	Irinotecan	[Not Available]	Chemotherapy	954	NO	1045	[Not Available]	7	[Not Available]	mg	mg	165	4	IV	PROGRESSION	[Not Applicable]	1085	[Not Available]
abe658e0-33f9-4f57-849b-dec4d20964d6	TCGA-G4-6314	TCGA-G4-6314-D21814	e59c220a-3767-418d-a106-a86a8ac11057	2012-2-9	Fluorouracil	[Not Available]	Chemotherapy	103	NO	209	[Not Available]	8	[Not Available]	mg	mg	752	2	IV	ADJUVANT	[Not Applicable]	6000	[Not Available]
abe658e0-33f9-4f57-849b-dec4d20964d6	TCGA-G4-6314	TCGA-G4-6314-D21821	6b644f7b-34e8-4860-ab40-d199dd3202cd	2012-2-9	Cetuximab	[Not Available]	Chemotherapy	954	NO	1045	[Not Available]	7	[Not Available]	mg	mg	825	4	IV	PROGRESSION	[Not Applicable]	5765	[Not Available]
ca5b878f-8bff-410a-8e6e-b1c133018c8d	TCGA-G4-6315	TCGA-G4-6315-D21985	9a8027b9-bdd9-4354-a3df-7c8b335184b3	2012-1-27	Fluorouracil	[Not Available]	Chemotherapy	40	NO	180	[Not Available]	10	[Not Available]	mg	mg	672	1	IV	ADJUVANT	[Not Applicable]	6742	[Not Available]
ca5b878f-8bff-410a-8e6e-b1c133018c8d	TCGA-G4-6315	TCGA-G4-6315-D21990	ac5b93fb-3aa7-4ff2-8699-5acfe146f59e	2012-1-27	Oxaliplatin	[Not Available]	Chemotherapy	40	NO	138	[Not Available]	8	[Not Available]	mg	mg	143	1	IV	ADJUVANT	[Not Applicable]	1136	[Not Available]
ca5b878f-8bff-410a-8e6e-b1c133018c8d	TCGA-G4-6315	TCGA-G4-6315-D21992	fcc343e4-8a19-46af-93e6-fe2c4ef5ad4b	2012-1-27	Bevacizumab	[Not Available]	Chemotherapy	40	NO	180	[Not Available]	11	[Not Available]	mg	mg	298	1	IV	ADJUVANT	[Not Applicable]	3267	[Not Available]
da21e143-dbf6-4ac7-8872-f1d9ae39512d	TCGA-G4-6320	TCGA-G4-6320-D21914	2b3677bc-4ef6-4226-ac39-22c5a2c4e2cd	2012-1-30	Leucovorin	[Not Available]	Chemotherapy	41	NO	209	[Not Available]	12	[Not Available]	mg	mg	1068	1	IV	ADJUVANT	[Not Applicable]	12816	[Not Available]
da21e143-dbf6-4ac7-8872-f1d9ae39512d	TCGA-G4-6320	TCGA-G4-6320-D21911	cc241491-1bbe-4a4e-bce5-52b8b63d0f39	2012-1-30	Oxaliplatin	[Not Available]	Chemotherapy	41	NO	145	[Not Available]	8	[Not Available]	mg	mg	227	1	IV	ADJUVANT	[Not Applicable]	1600	[Not Available]
da21e143-dbf6-4ac7-8872-f1d9ae39512d	TCGA-G4-6320	TCGA-G4-6320-D21913	536049c4-8854-4618-8702-adba0c21b59c	2012-1-30	Fluorouracil	[Not Available]	Chemotherapy	41	NO	209	[Not Available]	12	[Not Available]	mg/m2	mg/m2	400	1	IV	ADJUVANT	[Not Applicable]	4800	[Not Available]
e7dbfca1-9657-4952-8e0d-dec6373dda5b	TCGA-G4-6321	TCGA-G4-6321-D21918	939cf32b-c067-4fe7-b0d4-5ab549c56393	2012-1-30	Fluorouracil	[Not Available]	Chemotherapy	103	NO	257	[Not Available]	12	[Not Available]	mg	mg	824	1	IV	ADJUVANT	[Not Applicable]	9680	[Not Available]
e7dbfca1-9657-4952-8e0d-dec6373dda5b	TCGA-G4-6321	TCGA-G4-6321-D21919	cdfb2842-633d-48b2-8a2b-47d9c6ffa86e	2012-1-30	Leucovorin	[Not Available]	Chemotherapy	103	NO	257	[Not Available]	12	[Not Available]	mg	mg	824	1	IV	ADJUVANT	[Not Applicable]	9680	[Not Available]
e7dbfca1-9657-4952-8e0d-dec6373dda5b	TCGA-G4-6321	TCGA-G4-6321-D21917	2de2d207-7fac-4c6a-b0b3-57c575eff4f3	2012-2-22	Oxaliplatin	[Not Available]	Chemotherapy	103	NO	243	[Not Available]	11	[Not Available]	mg	mg	175	1	IV	ADJUVANT	[Not Applicable]	1890	[Not Available]
b3fea9bb-53f9-4ddb-922d-b570562d7a7d	TCGA-G4-6322	TCGA-G4-6322-D21963	9f9a389b-abde-4403-819f-44e648bcc4b2	2012-1-30	Leucovorin	[Not Available]	Chemotherapy	36	NO	190	[Not Available]	12	[Not Available]	mg	mg	844	1	IV	ADJUVANT	[Not Applicable]	10096	[Not Available]
b3fea9bb-53f9-4ddb-922d-b570562d7a7d	TCGA-G4-6322	TCGA-G4-6322-D21962	48474a61-d438-4c32-8b45-e077144102f9	2012-1-30	Fluorouracil	[Not Available]	Chemotherapy	36	NO	190	[Not Available]	12	[Not Available]	mg	mg	844	1	IV	ADJUVANT	[Not Applicable]	10096	[Not Available]
b3fea9bb-53f9-4ddb-922d-b570562d7a7d	TCGA-G4-6322	TCGA-G4-6322-D21961	609871f8-cee5-4029-bf5c-1f625ca7472f	2012-1-30	Oxaliplatin	[Not Available]	Chemotherapy	36	NO	190	[Not Available]	12	[Not Available]	mg	mg	180	1	IV	ADJUVANT	[Not Applicable]	2148	[Not Available]
